PET Radiopharmaceuticals Market Report

Global and Region PET Radiopharmaceuticals Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：225
  • REPORT CODE：GMM1005893
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of PET Radiopharmaceuticals market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of PET Radiopharmaceuticalsmarket, defines the market attractiveness level of PET Radiopharmaceuticals market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of PET Radiopharmaceuticals industry, describes the types of PET Radiopharmaceuticals market, the applications of major players and the market size, and deeply analyzes the current situation of the global PET Radiopharmaceuticals market and the development prospects and opportunities of PET Radiopharmaceuticals industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global PET Radiopharmaceuticals market in Chapter 13.

    By Player:

    • Eczacibasi-Monrol Nuclear Products (Turkey)

    • Lantheus Medical Imaging, Inc (US)

    • Bayer AG (Germany)

    • Bracco Imaging SpA (Italy)

    • IBA Molecular Imaging (Belgium)

    • Cardinal Health Inc (US)

    • Mallinckrodt plc (Ireland)

    • Nordion, Inc (Canada)

    • GE Healthcare (UK)

    • Advanced Accelerator Applications SA (France)

    By Type:

    • F-18

    • Ru-82

    • Others

    By End-User:

    • Oncology

    • Cardiology

    • Neurology

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 PET Radiopharmaceuticals Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 PET Radiopharmaceuticals Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 PET Radiopharmaceuticals Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 PET Radiopharmaceuticals Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise PET Radiopharmaceuticals Market Analysis and Outlook to 2022

    • 7.1 Global PET Radiopharmaceuticals Consumption (2017-2022)

    • 7.2 United States PET Radiopharmaceuticals Consumption (2017-2022)

    • 7.3 Europe PET Radiopharmaceuticals Consumption (2017-2022)

    • 7.4 China PET Radiopharmaceuticals Consumption (2017-2022)

    • 7.5 Japan PET Radiopharmaceuticals Consumption (2017-2022)

    • 7.6 India PET Radiopharmaceuticals Consumption (2017-2022)

    • 7.7 South Korea PET Radiopharmaceuticals Consumption (2017-2022)

    8 Region and Country-wise PET Radiopharmaceuticals Market Analysis and Outlook to 2028

    • 8.1 Global PET Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.2 United States PET Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.3 Europe PET Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.4 China PET Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.5 Japan PET Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.6 India PET Radiopharmaceuticals Consumption Forecast (2022-2028)

    • 8.7 South Korea PET Radiopharmaceuticals Consumption Forecast (2022-2028)

    9 Global PET Radiopharmaceuticals Market Outlook by Types and Applications to 2022

    • 9.1 Global PET Radiopharmaceuticals Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global F-18 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Ru-82 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global PET Radiopharmaceuticals Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Neurology Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global PET Radiopharmaceuticals Market Outlook by Types and Applications to 2028

    • 10.1 Global PET Radiopharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global F-18 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Ru-82 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global PET Radiopharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Neurology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global PET Radiopharmaceuticals Import and Export Analysis (Top 5 Countries)

    • 11.1 Global PET Radiopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global PET Radiopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 PET Radiopharmaceuticals Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global PET Radiopharmaceuticals Market Competitive Analysis

    • 14.1 Eczacibasi-Monrol Nuclear Products (Turkey)

      • 14.1.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Details

      • 14.1.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Service

    • 14.2 Lantheus Medical Imaging, Inc (US)

      • 14.2.1 Lantheus Medical Imaging, Inc (US) Company Details

      • 14.2.2 Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Product and Service

    • 14.3 Bayer AG (Germany)

      • 14.3.1 Bayer AG (Germany) Company Details

      • 14.3.2 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG (Germany) PET Radiopharmaceuticals Product and Service

    • 14.4 Bracco Imaging SpA (Italy)

      • 14.4.1 Bracco Imaging SpA (Italy) Company Details

      • 14.4.2 Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Product and Service

    • 14.5 IBA Molecular Imaging (Belgium)

      • 14.5.1 IBA Molecular Imaging (Belgium) Company Details

      • 14.5.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Service

    • 14.6 Cardinal Health Inc (US)

      • 14.6.1 Cardinal Health Inc (US) Company Details

      • 14.6.2 Cardinal Health Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Cardinal Health Inc (US) PET Radiopharmaceuticals Product and Service

    • 14.7 Mallinckrodt plc (Ireland)

      • 14.7.1 Mallinckrodt plc (Ireland) Company Details

      • 14.7.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Service

    • 14.8 Nordion, Inc (Canada)

      • 14.8.1 Nordion, Inc (Canada) Company Details

      • 14.8.2 Nordion, Inc (Canada) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Nordion, Inc (Canada) PET Radiopharmaceuticals Product and Service

    • 14.9 GE Healthcare (UK)

      • 14.9.1 GE Healthcare (UK) Company Details

      • 14.9.2 GE Healthcare (UK) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GE Healthcare (UK) PET Radiopharmaceuticals Product and Service

    • 14.10 Advanced Accelerator Applications SA (France)

      • 14.10.1 Advanced Accelerator Applications SA (France) Company Details

      • 14.10.2 Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of PET Radiopharmaceuticals

    • Figure PET Radiopharmaceuticals Picture

    • Table Global PET Radiopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global PET Radiopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global PET Radiopharmaceuticals Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global PET Radiopharmaceuticals Consumption by Country (2017-2022)

    • Figure United States PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Europe PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure China PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Japan PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure India PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Korea PET Radiopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global PET Radiopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure United States PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure China PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure India PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea PET Radiopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global F-18 Consumption and Growth Rate (2017-2022)

    • Figure Global Ru-82 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiology Consumption and Growth Rate (2017-2022)

    • Figure Global Neurology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global F-18 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ru-82 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global PET Radiopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • Table Global PET Radiopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) (Foundation Year, Company Profile and etc.)

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product and Service

    • Table Lantheus Medical Imaging, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus Medical Imaging, Inc (US) PET Radiopharmaceuticals Product and Service

    • Table Bayer AG (Germany) (Foundation Year, Company Profile and etc.)

    • Table Bayer AG (Germany) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG (Germany) PET Radiopharmaceuticals Product and Service

    • Table Bracco Imaging SpA (Italy) (Foundation Year, Company Profile and etc.)

    • Table Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging SpA (Italy) PET Radiopharmaceuticals Product and Service

    • Table IBA Molecular Imaging (Belgium) (Foundation Year, Company Profile and etc.)

    • Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product and Service

    • Table Cardinal Health Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Cardinal Health Inc (US) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cardinal Health Inc (US) PET Radiopharmaceuticals Product and Service

    • Table Mallinckrodt plc (Ireland) (Foundation Year, Company Profile and etc.)

    • Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product and Service

    • Table Nordion, Inc (Canada) (Foundation Year, Company Profile and etc.)

    • Table Nordion, Inc (Canada) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nordion, Inc (Canada) PET Radiopharmaceuticals Product and Service

    • Table GE Healthcare (UK) (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare (UK) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare (UK) PET Radiopharmaceuticals Product and Service

    • Table Advanced Accelerator Applications SA (France) (Foundation Year, Company Profile and etc.)

    • Table Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Accelerator Applications SA (France) PET Radiopharmaceuticals Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US